We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Pharmacokinetics and Pharmacodynamics”. The paper list is as follows:

1. “Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential”
by Young Yoon Bang, Im-Sook Song, Min Seo Lee, Chang Ho Lim, Yong-Yeon Cho, Joo Young Lee, Han Chang Kang and Hye Suk Lee
Pharmaceutics 2022, 14(4), 774; https://doi.org/10.3390/pharmaceutics14040774
Available online: https://www.mdpi.com/1999-4923/14/4/774

2. “Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution”
by Hinojal Zazo, Clara I. Colino, Carmen Gutiérrez-Millán, Andres A. Cordero, Matthias Bartneck and José M. Lanao
Pharmaceutics 2022, 14(2), 406; https://doi.org/10.3390/pharmaceutics14020406
Available online: https://www.mdpi.com/1999-4923/14/2/406

3. “Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations”
by Alexander Janssen, Frank C. Bennis and Ron A. A. Mathôt
Pharmaceutics 2022, 14(9), 1814; https://doi.org/10.3390/pharmaceutics14091814
Available online: https://www.mdpi.com/1999-4923/14/9/1814

4. “Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line”
by Maria Smirnova, Laura Goracci, Gabriele Cruciani, Laetitia Federici, Xavier Declèves, Hélène Chapy and Salvatore Cisternino
Pharmaceutics 2022, 14(2), 255; https://doi.org/10.3390/pharmaceutics14020255
Available online: https://www.mdpi.com/1999-4923/14/2/255

5. “Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis”
by Karine Rodríguez-Fernández, Víctor Mangas-Sanjuán, Matilde Merino-Sanjuán, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Mónica Climente-Martí and Elena Gras-Colomer
Pharmaceutics 2022, 14(3), 654; https://doi.org/10.3390/pharmaceutics14030654
Available online: https://www.mdpi.com/1999-4923/14/3/654

6. “Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management”
by Rannissa Puspita Jayanti, Nguyen Phuoc Long, Nguyen Ky Phat, Yong-Soon Cho and Jae-Gook Shin
Pharmaceutics 2022, 14(5), 990; https://doi.org/10.3390/pharmaceutics14050990
Available online: https://www.mdpi.com/1999-4923/14/5/990

7. “Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions”
by Helena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, Dominik Selzer and Thorsten Lehr
Pharmaceutics 2022, 14(5), 915; https://doi.org/10.3390/pharmaceutics14050915
Available online: https://www.mdpi.com/1999-4923/14/5/915

8. “Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination”
by Eric D. Eisenmann, Dominique A. Garrison, Zahra Talebi, Yan Jin, Josie A. Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R. Savona, Alice S. Mims and Sharyn D. Baker
Pharmaceutics 2022, 14(4), 694; https://doi.org/10.3390/pharmaceutics14040694
Available online: https://www.mdpi.com/1999-4923/14/4/694

9. “Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations”
by Hyeon-Cheol Jeong, Min-Gul Kim, Zhuodu Wei, Kyeong-Ryoon Lee, Jaehyeok Lee, Im-Sook Song and Kwang-Hee Shin
Pharmaceutics 2022, 14(6), 1298; https://doi.org/10.3390/pharmaceutics14061298
Available online: https://www.mdpi.com/1999-4923/14/6/1298

You can check all publications in the Section “Pharmacokinetics and Pharmacodynamics” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1032.